Gale, Nathan http://orcid.org/0000-0002-7215-1225
McEwan, Michael
Camacho, Oscar M.
Hardie, George
Proctor, Christopher J.
Murphy, James
Funding for this research was provided by:
British American Tobacco (Investments) Ltd
Article History
Received: 9 April 2021
Accepted: 15 June 2021
First Online: 1 July 2021
Declarations
:
: NG, MM, OMC and GH are current employees of British American Tobacco (Investments) Limited, which was the sponsor and funding source of this study. JM was an employee of British American Tobacco (Investments) Limited at the time of the study and is a current employee of R. J. Reynolds Tobacco Company. CJP was an employee of British American Tobacco (Investments) Limited at the time of the study and is currently contracted by British American Tobacco (Investments) Limited to provide consultancy services. The British American Tobacco Group is the manufacturer and holder of the intellectual property rights of the investigational product used in this study.
: This study was granted a Favourable Opinion (equivalent to Institutional Review Board approval) by NHS Health Research Authority Wales Research Ethics Committee 2 (reference number 17/WA/0212).
: All participants provided written informed consent before enrolment into the study, including agreeing for the results to be published.